Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study.
Khorshiddoust RR, Khorshiddoust SR, Hosseinabadi T, Mottaghitalab F, Mokhtari F, Azadinia F, Mozdarani H, Shabani M, Emadi-Kouchak H, Taheri B, Khani-Juyabad F, Kashani MA, Sadoughi A, Zamanizadeh S, Maddah H, Aminzadeh M, Khanaki M, Saremi S, Rad AP, Fatehi A, Rad MG, Haftbaradaran M, Khosroshahi M, Sadeghi M, Aminnayeri M, Jafari S, Ghiasvand F, Seifi A, Ghaderkhani S, Manshadi SAD, Salehi M, Abbasian L, Hasannezhad M, Meidani M, Hajiabdolbaghi M, Ahmadinejad Z, Parash M, Sedighi Z, Mohammadian A.
Khorshiddoust RR, et al.
Biomed Pharmacother. 2022 May;149:112729. doi: 10.1016/j.biopha.2022.112729. Epub 2022 Feb 17.
Biomed Pharmacother. 2022.
PMID: 35276467
Free PMC article.
Clinical Trial.